Evidence map›Paper›PMID 26723575›Full record

ReviewBone2016

MicroRNA variants as genetic determinants of bone mass.

Neha S Dole, Anne M Delany

Abstract readReview
In one paragraph

Review in Bone, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. miR-338-3p regulates osteoclastogenesis via targeting IKKβ gene.In vitro cellular & developmental biology. Animal · 2019
    Article
  7. Review
  8. miR-219a-5p Regulates Rorβ During Osteoblast Differentiation and in Age-related Bone Loss.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Article
  9. Article
  10. Epigenetics of Skeletal Diseases.Current osteoporosis reports · 2018
    Review
  11. Article
  12. Article
  13. MicroRNAs in bone diseases.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Neha S DoleCenter for Molecular Medicine, UCONN Health, Farmington, CT, USA. Electronic address: nehashashank.dole@ucsf.edu.
Anne M DelanyCenter for Molecular Medicine, UCONN Health, Farmington, CT, USA. Electronic address: adelany@uchc.edu.
UConn Health · US

Funding

Function and Regulation of Osteonectin in BoneR01AR044877 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DELANY, ANNE M · 2003 to 2013
$2.6M
Function and Regulation of Osteonectin in BoneR56AR044877 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DELANY, ANNE M · 2008 to 2008
$319k
FUNCTION AND REGULATION OF OSTEONECTIN IN BONER29AR044877 · NIAMS · ST. FRANCIS HOSPITAL AND MEDICAL CENTER · PI DELANY, ANNE M · 1998 to 2002
$298k
NIAMS NIH HHS AR044877NIAMS NIH HHS R01 AR044877NIAMS NIH HHS R29 AR044877NIAMS NIH HHS R56 AR044877
6 · The paper itself

Abstract

Single nucleotide polymorphisms (SNPs) are the most abundant genetic variants that contribute to the heritability of bone mass. MicroRNAs (miRNAs, miRs) are key post-transcriptional regulators that modulate the differentiation and function of skeletal cells by targeting multiple genes in the same or distinct signaling pathways. SNPs in miRNA genes and miRNA binding sites can alter miRNA abundance and mRNA targeting. This review describes the potential impact of miRNA-related SNPs on skeletal phenotype. Although many associations between SNPs and bone mass have been described, this review is limited to gene variants for which a function has been experimentally validated. SNPs in miRNA genes (miR-SNPs) that impair miRNA processing and alter the abundance of mature miRNA are discussed for miR-146a, miR-125a, miR-196a, miR-149 and miR-27a. SNPs in miRNA targeting sites (miR-TS-SNPs) that alter miRNA binding are described for the bone remodeling genes bone morphogenetic protein receptor 1 (Bmpr1), fibroblast growth factor 2 (Fgf2), osteonectin (Sparc) and histone deacetylase 5 (Hdac5). The review highlights two aspects of miRNA-associated SNPs: the mechanism for altering miRNA mediated gene regulation and the potential of miR-associated SNPs to alter osteoblast, osteoclast or chondrocyte differentiation and function. Given the polygenic nature of skeletal diseases like osteoporosis and osteoarthritis, validating the function of additional miRNA-associated SNPs has the potential to enhance our understanding of the genetic determinants of bone mass and predisposition to selected skeletal diseases.

Indexed as

Bone DensityBone DiseasesHumansMicroRNAsModels, GeneticPolymorphism, Single NucleotideMicroRNAsmiRNAOsteoarthritisOsteoblastOsteoclastOsteoporosisSNP

Identifiers

PMID26723575
PMCPMC4755870
OpenAlexW2198134094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.